Urinary tract infection (UTI) is a common diagnosis among residents in long-term care (LTC) settings, and a common reason to prescribe antibiotics. The annual prevalence of antibiotic use in LTC is high -- between 47% and 79% ([@b1-idmm-26-133]), or 5.9% of all residents on a given day ([@b2-idmm-26-133]). The rate of antibiotic use without adequate clinical rationale has been reported to be as high as 38% in 42 facilities ([@b3-idmm-26-133]) and 42% in one facility ([@b4-idmm-26-133]).

Attention to antimicrobial stewardship through appropriate antibiotic use can reduce drug costs ([@b5-idmm-26-133]), and can reduce *Clostridium difficile* diarrhea rates in LTC ([@b6-idmm-26-133]). For these reasons, LTC is an appropriate population in which to study antibiotic stewardship and to intervene to improve use. A cluster randomized study has shown that implementing consensus treatment guidelines for UTI in LTC can reduce antibiotic consumption for UTI ([@b7-idmm-26-133]).

Residents of LTC facilities without indwelling urinary catheters have a prevalence of asymptomatic bacteriuria (\>10^8^ colony-forming units/L) of approximately 40% ([@b8-idmm-26-133]). Screening for or treatment of asymptomatic bacteriuria is not associated with reduction in mortality ([@b8-idmm-26-133]--[@b10-idmm-26-133]), and may contribute to inappropriate antibiotic use, which drives the selection of antibiotic resistance among bacteria in the patient's resident flora ([@b11-idmm-26-133]).

Among LTC residents with a change in clinical status, positive urine culture is often interpreted as the cause, leading to overdiagnosis of UTI. In a recent prospective study involving 399 clinically suspected UTI episodes, there was very poor correlation among symptoms, urine culture results and the decision to use antibiotics ([@b12-idmm-26-133]). A multivariate logistic regression for factors associated with bacteriuria and pyuria revealed that dysuria, change in character of urine and change in mental status were statistically associated with bacteriuria and pyuria, although associations were weak (RR 1.38 to 1.58). Clearly, the diagnosis and treatment of UTI in LTC is not simple or consistent, and evidence to guide the decision to collect urine culture is not available.

Confounding the assessment of the relationship between these three clinical variables and positive laboratory results is the fact that clinical decline, for various reasons, can lead to dehydration, causing a change in character of urine and change in mental status. These signs are often considered to be the result of a UTI (rather than dehydration) and treated as such. Residents with cognitive impairment are more likely to have positive urine cultures ([@b8-idmm-26-133]) and are also more vulnerable to delirium, which frequently leads clinicians to interpret a causal relationship between changes in mentation and bacteriuria. To date, no study has considered the clinical outcome after antibiotic therapy to validate the diagnostic criteria. We performed a prospective observational efficacy study to identify symptoms associated with a positive urine culture, and assessed clinical response to antibiotic therapy.

METHODS
=======

Six LTC facilities in St John's, Newfoundland and Labrador, ranging from 40 beds to 377 beds, were selected for inclusion based on their high urine culture submission rates. Consecutive urine samples received in the central microbiology laboratory from these LTC facilities between June 24 and July 17, 2013 and between January 20 and March 20, 2014 were identified, and a research associate visited the relevant facility on the day of submission. Receipt of urine for culture was considered to be evidence that nursing staff suspected UTI. Exclusion criteria were applied as follows: Not anticipated to remain in the nursing home for LTC (ie, short-term residents or pending discharge);Anticipated life expectancy \<4 weeks as assessed by nursing staff;\<65 years of age;Indwelling catheter or surgical urinary collection device;Current renal dialysis;Current anti-infective therapy for any reason;Resided in the nursing home for \<4 weeks (providers did not have adequate time to determine resident's baseline functional status).

The study was approved by local health research ethics authority to approach nursing staff for consent to participate. Consent forms and study information sheets were circulated to LTC facilities before the study. The nurse (or delegate) who collected the urine specimen was identified and interviewed on the day of collection, and again after two days and five to seven days. Patient information, including comorbidity and baseline functional capacity (28-point activities of daily living \[ADL\] scale including mobility in bed, transfers, locomotion, dressing, toileting, personal hygiene and feeding, and four-point mental status scale \[[@b12-idmm-26-133]\]), was collected from the nurse. The patient, the family, the caregivers and the attending physician were not interviewed. Urine culture was performed quantitatively, according to laboratory protocol.

Univariate logistic regression was performed using SPSS version 20.0 (IBM Corporation, USA) to determine whether nurse-reported clinical symptoms were associated with the primary outcome: growth of at least 10^8^ colony-forming units/L of uropathogenic bacteria in urine culture. Symptoms and functional status were described over time. Change in ADL score over time was analyzed using a paired-samples *t* test (two-sided).

Variable(s) considered to be potentially predictive of significant growth included demographic characteristics (age, sex, LTC facility, total comorbidities), reasons for collection (change in mental status, change in behaviour, change in character of urine, fever, change in gait or fall, change in voiding pattern, flank pain, patient or family request, abnormal laboratory test result, dysuria, change in functional status, previous UTI, malaise), baseline functional capabilities (ADL score, disorganized speech in the past seven days, altered perception in the past seven days, unresponsive episodes in the past seven days and lethargy in the past seven days), and nurse-reported symptoms (fever, change in behaviour, change in mental status, diarrhea, abdominal pain, shortness of breath, weakness, dysuria, change in character of urine, change in frequency of urination and flank pain). Variables with ≤2 positive responses were removed (change in functional status, change in gait or fall, results of other workup performed, other concurrent infection, dehydration, shortness of breath, syncope, diarrhea, baseline unresponsiveness, cough).

RESULTS
=======

A total of 174 urine specimens were considered, and 101 episodes from 101 patients were observed ([Figure 1](#f1-idmm-26-133){ref-type="fig"}). Thirty-eight (37.6%) of 101 episodes demonstrated significant growth of bacteria in urine. In 36.6% of episodes, the nurse making the decision to collect urine was interviewed; in other episodes, alternate nurses also familiar with the patient were interviewed. Patient demographics are summarized in [Table 1](#t1-idmm-26-133){ref-type="table"}. The mean (± SD) age was 84.0±8.6 years, 79.2% were women and there were a mean of 1.8±1.0 comorbidities per patient. Baseline ADL score was 11.9±8.7, with zero representing total independence and 28 representing total dependence.

Predefined reasons for urine collection ranged from one to seven reasons (mean 2.0 reasons), and are listed in descending order of frequency in [Table 2](#t2-idmm-26-133){ref-type="table"}. The previously described significant clinical predictors (dysuria, change in character of urine and change in mental status) were among the most common reasons. Other reasons for collection included pyuria (n=4 patients), hyperglycemia (n=2), test of cure (n=1), urine retention (n=1), hematuria (n=1), "routine checkup" (n=1), abdominal pain (n=1), previous sample mixed growth (n=1) and doctor's request (n=1).

Most episodes did not have adequate record of vital signs or blood testing performed to apply published diagnostic criteria. Body temperature was measured for eight (7.9%) episodes, blood pressure was measured for six (5.9%) episodes, a dipstick test was performed for 25 (24.8%) episodes and a complete blood count was obtained for 16 (15.8%) episodes. Among 38 urine specimens with significant growth, 25 (65.8%) grew *Escherichia coli*, five (10.5%) grew *Proteus* species, four (13.2%) grew *Klebsiella* species, three (7.9%) grew *Enterococcus* species and one (2.6%) grew yeast.

Using univariate regression, there were two predictors that were significantly associated with the outcome (male sex, RR 5.58 \[95% CI 1.23 to 25.43\]; and change in mental status, RR 13.83 \[95% CI 1.81 to 105.81\]). Change in character of urine approached significance (RR 14.51 \[95% CI 0.66 to 320.71\]) ([Table 3](#t3-idmm-26-133){ref-type="table"}).

Antibiotic treatment was given in 48 of 101 (47.5%) episodes ([Table 4](#t4-idmm-26-133){ref-type="table"}). Treatment decision did not correlate well with significant growth (kappa = 0.44). Nineteen (40%) of 48 of antibiotic prescriptions were given to patients without significant growth, and nine (17.0%) of 53 episodes with significant growth were not treated. Using univariate regression, no clinical or demographic variables were associated with the decision to treat. Significant growth was predictive of the decision to treat (RR 40.01 \[95% CI 4.00 to 401.53\]). Mean time between collection and treatment was 1.44 days (range eight days before collection to 10 days after collection). In 21 (43.8%) of 48 cases treated, treatment was given before preliminary culture results were provided. Among episodes with significant growth that were treated, four (14.3%) of 28 patients were given an antibiotic to which the bacteria was reported to be resistant.

ADL score at baseline (before decompensation prompting urine collection) was compared with ADL score at 48 h (the time period required for culture results to become available), and ADL score at five days (resolution of episode), in groups based on significant growth and treatment ([Table 5](#t5-idmm-26-133){ref-type="table"}). There was no significant difference observed in any group between baseline and 48 h, or between 48 h and five to seven days.

DISCUSSION
==========

The objective of the present study was to identify the symptoms or signs associated with the nurse's (or delegate's) decision to submit urine for culture, and to assess the clinical response to antibiotic therapy. We found two predictors of significant growth (male sex and change in mental status). Most examined clinical indicators were not significantly predictive of positive culture. A sex difference may have been related to a cleaner urine collection among males, leading to less mixed growth, or reflect patterns of urine collection among nurses.

Our study had significant limitations. Because of the small sample size, CIs for RRs were very wide. We considered input from nurses only, and family or physicians may have had different perceptions of clinical symptoms and signs. However, nurses in LTC make the decision to collect urine specimens. We were not able to interview the nurse who collected the specimen in many cases because that individual had finished the work shift. Nurses working on the next shift may not have completely understood the reasons for urine collection.

Our study demonstrates that the application of surveillance diagnostic criteria developed for LTC may be difficult, due to the lack of patient investigation performed in the LTC setting.

Consistent with previous studies ([@b13-idmm-26-133]), the observed rate of significant growth among patients with urine collected (38%) closely matches published rates of asymptomatic bacteriuria in this population (40% \[[@b8-idmm-26-133]\]), indicating that clinical suspicion has no predictive capacity. Pretest probability in the symptomatic patient equals pretest probability in the asymptomatic patient, meaning the clinical suspicion of the diagnosis of UTI is not contributory. The present study did not include patients with indwelling catheters, among whom the rate of bacteriuria would be expected to be higher.

Urine culture results did not influence physician prescription decisions because physicians chose to treat culture-negative patients, to not treat culture-positive patients, to treat before culture results, and to use antibiotics to which the laboratory reported the organisms to be resistant.

Furthermore, we observed no functional improvement from antibiotic treatment. ADL scores did not change over two days or seven days in any treatment group. Using this functional status outcome, neither the test result nor the therapy led to clinical benefit. Without a randomized design, culture-positive and culture-negative patients may have been different before the study began; thus, this estimate may be biased. Culture-positive patients who were not treated had worse ADL scores at baseline, suggesting that lower functioning patients may be selected for no treatment because of a poor prognosis. Although predictors for significant growth may be defined by observational studies, if treatment of significant growth does not lead to clinical improvement, then significant growth is not a suitable outcome. Further research should define UTI diagnostic criteria based on clinical benefit following successful treatment.

The present study was the first to observe clinical outcomes as a measure of effectiveness of diagnosis and treatment for UTI in LTC.

An editorial has suggested that there is adequate equipoise to propose a randomized trial comparing delayed antibiotic therapy with immediate antibiotic therapy, or comparing hydration to antibiotic therapy ([@b14-idmm-26-133]). A further suggestion to randomly assign LTC patients to management with urine culture or no urine culture appears to be reasonable. Further research regarding clinical outcomes is needed, including the effect of urine culture testing on mortality.

A laboratory policy to provide urine culture testing services only to selected LTC patients may reduce antibiotic consumption, although if physicians treat without culture results, this reduction would not be achieved. Requiring physicians to call the laboratory to receive urine culture reports reduced inappropriate treatment for asymptomatic bacteriuria among inpatients by 36% ([@b15-idmm-26-133]), suggesting that laboratory policy interventions may influence antimicrobial use significantly. At the same time, investigations such as blood culture could be encouraged. Blood culture results have greater specificity for infection and influence therapy more directly.

**AUTHOR CONTRIBUTIONS:** PD: proposal, ethics, analysis, manuscript; CP: data collection, analysis; SW: data collection; BB: manuscript editing; LN: manuscript editing.

![Participant recruitment](idmm-26-133-1){#f1-idmm-26-133}

###### 

Demographic characteristics

  **Characteristic (n=101)**                                               
  ------------------------------------------------------------------------ -----------
  Age, years, mean ± SD                                                    84.0±8.6
  Female sex, %                                                            79.2
  Number of comorbidities, mean ± SD                                       1.8±1.0
    Dementia                                                               58 (57.4)
    Stroke                                                                 13 (12.9)
    Liver disease                                                          1 (1.0)
    Depression                                                             41 (40.6)
    Kidney disease                                                         12 (11.9)
    Diabetes                                                               25 (24.8)
    Cancer                                                                 9 (8.9)
    Chronic obstructive pulmonary disease                                  15 (14.9)
  Baseline ADL score, mean ± SD (independent = 0, total dependence = 28)   11.9±8.7
  Mental status in past seven days                                         
    Disorganized speech                                                    12 (11.9)
    Altered perception                                                     19 (18.8)
    Unresponsiveness                                                       1 (1.0)
    Lethargy                                                               19 (18.8)

Data presented as n (%) unless otherwise indicated. ADL Activities of daily living

###### 

Reasons for urine culture collection (n=101)

  **Clinical reason**                **n (%)**
  ---------------------------------- -----------
  Change in behaviour                35 (34.7)
  Dysuria                            31 (30.7)
  Change in character of urine       30 (29.7)
  Change in mental status            26 (25.7)
  Change in voiding pattern          21 (20.8)
  Other reason                       14 (13.9)
  Patient or family request          11 (10.9)
  Previous urinary tract infection   11 (10.9)
  Flank pain                         8 (7.9)
  Malaise                            6 (5.9)
  Fever or chills                    5 (5.0)
  Abnormal laboratory test result    4 (4.0)
  Change in gait or fall             3 (3.0)
  Change in functional status        1 (1.0)

###### 

Univariate correlation of predictors with significant growth (n=38 of 101 episodes)

  **Characteristic**                   **n**   **RR**     **95% CI**      **P**
  ------------------------------------ ------- ---------- --------------- -------
    Age                                101     0.99       0.93--1.06      0.79
    Male sex                           21      5.58       1.23--25.43     0.026
    Total comorbidities                101     0.87       0.53--1.47      0.61
    Long-term care facility            101     1.39       0.95--2.02      0.087
  Stated reason for urine collection                                      
    Fever                              5       0.00                       1.0
    Change in voiding pattern          21      16.70      0.16--1754.36   0.24
    Patient or family request          11      0.12       0.007--1.91     0.13
    Abnormal laboratory test result    4       2.85       0.16--51.27     0.48
    Previous urinary tract infection   11      1.28       0.19--8.48      0.80
  Baseline functional capacity                                            
    Baseline ADL score                 101     1.03       0.97--1.10      0.38
    Baseline disorganized speech       12      1.02       0.14--7.59      0.97
    Baseline altered perception        19      0.36       0.05--2.60      0.31
    Baseline periods of lethargy       19      4.20       0.91--19.37     0.065
  New symptoms                                                            
    Change in behaviour                32      3.41       0.11--104.90    0.48
    Change in mental status            37      13.83      1.81--105.81    0.011
    Abdominal pain                     10      0.68       0.083--5.60     0.72
    Weakness                           10      0.90       0.026--30.91    0.95
    Worsening in ADL score             4       0.00                       1.0
    Dysuria                            32      2.10       0.14--32.13     0.60
    Change in character of urine       30      14.51      0.66--320.71    0.090
    Flank pain                         9       infinity                   1.0
    Change in frequency of urination   23      0.079      0.002--2.62     0.16

ADL Activities of daily living

###### 

Treatment decision

  **Treatment decision**      **Growth**                                             **Total**                                               
  --------------------------- ------------------------------------------------------ ------------------------------------------------------- -----
  Antibiotic prescribed       29 (60)                                                19 (40)[^\*^](#tfn4-idmm-26-133){ref-type="table-fn"}   48
  Antibiotic not prescribed   9 (17)[^\*^](#tfn4-idmm-26-133){ref-type="table-fn"}   44 (83)                                                 53
  Total                       38                                                     63                                                      101

Data presented as n or n (%).

Inappropriate treatment decision

###### 

Change in activities of daily living (ADL) score[^\*^](#tfn5-idmm-26-133){ref-type="table-fn"}

  **Group**                       **n**   **Mean ADL, baseline**   **Mean ADL, 48 h**   **P, baseline to 48 h**   **Mean ADL, 5--7 days**   **P, 48 h to 5--7 days**
  ------------------------------- ------- ------------------------ -------------------- ------------------------- ------------------------- --------------------------
  Culture positive, treated       28      11.5                     12.2                 0.30                      12.2                      No difference
  Culture positive, not treated   9       17.6                     16.4                 0.35                      16.4                      No difference
  Culture negative, treated       18      12.1                     12.1                 No difference             12.1                      No difference
  Culture negative, not treated   44      10.9                     11.2                 0.29                      11.3                      0.34

Zero represents total independence, 28 represents total dependence
